William Keller
Chairman chez COLAND HOLDINGS LIMITED
Fortune : 40 013 $ au 31/03/2024
Profil
William Robert Keller founded Keller Pharma Consultancy (Shanghai) Co. Ltd.
in 2003, where he worked as General Manager from 2012 to 2014.
Mr. Keller also currently works at Coland Holdings Ltd., as Chairman from 2010, Hua Medicine Ltd., as Independent Non-Executive Director, Shanghai Guo Chuang Pharmaceutical Co., Ltd., as Director from 2020, Cathay Biotech, Inc., as Director from 2019, Wuxi Biologics (Cayman), Inc., as Independent Non-Executive Director from 2017, Pharmaceutical Association of Shijiazhuang City, as President, and Roche Diagnóstica Brasil Ltda, as Vice President.
Mr. Keller also formerly worked at HBM BioMed China Partners Ltd, as Chairman from 2009 to 2010, Coland Pharmaceutical Co., Ltd., as Chairman from 2010 to 2020, Shanghai Association of Enterprises With Foreign Investment, as Vice Chairman from 1997 to 2013, Alexion Pharmaceuticals, Inc., as Independent Director from 2009 to 2015, Wuxi PharmaTech (Cayman), Inc., as Independent Director from 2014 to 2015, China Nuokang Bio-Pharmaceutical, Inc., as Independent Director from 2010 to 2011, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., as Director, Cathay Industrial Biotech Ltd., as Director from 2008 to 2011, Fosun Pharma Group Co. Ltd., as Independent Director, Artisan Acquisition Corp., as Independent Director, Hoffmann-La Roche, Inc., as General Manager from 1972 to 2003, Productos Roche SA, as General Manager, TaiGen Biopharmaceuticals Holdings Ltd., as Member-Supervisory Board from 2011 to 2014, Shanghai Roche Pharmaceutical Co., Ltd., as General Manager from 1994 to 2003, Roche (China) Co. Ltd., as General Manager from 1994 to 2003, Produtos Roche Químicos e Farmacêuticos SA, as Deputy General Manager, and Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd, as Deputy General Manager from 2003 to 2014.
Mr. Keller received his undergraduate degree in 1972 from School of Economics & Business Administration.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 21 899 ( 0,00% ) | 40 013 $ | 31/03/2024 |
Postes actifs de William Keller
| Sociétés | Poste | Début |
|---|---|---|
| COLAND HOLDINGS LIMITED | Chairman | 05/12/2010 |
| WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | 17/05/2017 |
| HUA MEDICINE (SHANGHAI) LTD. | Director/Board Member | - |
| CATHAY BIOTECH INC. | Director/Board Member | 18/08/2019 |
| Roche Diagnóstica Brasil Ltda | Corporate Officer/Principal | - |
| Pharmaceutical Association of Shijiazhuang City | President | - |
Shanghai Guo Chuang Pharmaceutical Co., Ltd.
 Shanghai Guo Chuang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Guo Chuang Pharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceuticals against nervous system diseases, digestive system diseases, cardiovascular diseases, mental diseases, and immune system diseases. The company was founded on March 20, 2003 and is headquartered in Shanghai, China. | Director/Board Member | 01/12/2020 |
Anciens postes connus de William Keller
| Sociétés | Poste | Fin |
|---|---|---|
Coland Pharmaceutical Co., Ltd.
 Coland Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Coland Pharmaceutical is a specialty pharmaceutical company focusing on marketing branded products and developing solid pipelines through collaboration with leading institutes. Its main interests are in the dedicated therapeutic areas Hepatitis, Immunology, Oncology, and other niche areas. Coland was started its sales operation in 2005. Daiding (Adefovir), a first-to-market generic that treats HBV was launched in 2005. With effective promotion, and brand building, Daiding achieved great success and gained the leading position in China. Its goal is to become a leading specialty pharmaceutical company in China with strong sales and marketing capabilities and solid product pipelines. The company was founded in 2003 and is headquartered in Shanghai, China. | Chairman | 01/12/2020 |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Director/Board Member | 01/12/2015 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de William Keller
| School of Economics & Business Administration | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Health Technology |
| HUA MEDICINE (SHANGHAI) LTD. | Health Technology |
| WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
| CATHAY BIOTECH INC. | Process Industries |
| Entreprise privées | 20 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Wuxi PharmaTech (Cayman), Inc.
 Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
China Nuokang Bio-Pharmaceutical, Inc.
 China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Cathay Industrial Biotech Ltd.
 Cathay Industrial Biotech Ltd. Chemicals: SpecialtyProcess Industries Cathay Industrial Biotech Ltd. develops, manufactures, and commercializes chemicals, fuels, and polymers. It offers dibasic acids, pentamethylene diamine, terryl for textiles, engineering polymers, toll production, and technology development. The company was founded by XiuCai Liu and QiXian Zhang in 1997 and is headquartered in Shanghai, China. | Process Industries |
| Productos Roche SA | |
HBM BioMed China Partners Ltd
 HBM BioMed China Partners Ltd Investment ManagersFinance HBM BioMed China Partners Ltd. is a venture capital fund focused on biomedical investments in companies based in China. | Finance |
| Pharmaceutical Association of Shijiazhuang City | |
Shanghai Roche Pharmaceutical Co., Ltd.
 Shanghai Roche Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche (China) Co. Ltd., Shanghai Roche Pharmaceutical Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Shanghai, China. | Health Technology |
| Roche (China) Co. Ltd. | |
| Produtos Roche Químicos e Farmacêuticos SA | |
| Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd | |
| Keller Pharma Consultancy (Shanghai) Co. Ltd. | |
Coland Pharmaceutical Co., Ltd.
Coland Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Coland Pharmaceutical is a specialty pharmaceutical company focusing on marketing branded products and developing solid pipelines through collaboration with leading institutes. Its main interests are in the dedicated therapeutic areas Hepatitis, Immunology, Oncology, and other niche areas. Coland was started its sales operation in 2005. Daiding (Adefovir), a first-to-market generic that treats HBV was launched in 2005. With effective promotion, and brand building, Daiding achieved great success and gained the leading position in China. Its goal is to become a leading specialty pharmaceutical company in China with strong sales and marketing capabilities and solid product pipelines. The company was founded in 2003 and is headquartered in Shanghai, China. | Health Technology |
Coland Holdings Ltd.
 Coland Holdings Ltd. Pharmaceuticals: MajorHealth Technology Coland Holdings Ltd. engages in the research, development, and sale of generic and traditional Chinese medicine, biochemical drugs, and medical equipment. It focuses on the treatment of hepatobiliary, respiratory system, tumor, and cardiovascular problems. The company was founded on March 23, 2010 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai Association of Enterprises With Foreign Investment | |
Shanghai Guo Chuang Pharmaceutical Co., Ltd.
Shanghai Guo Chuang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Guo Chuang Pharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceuticals against nervous system diseases, digestive system diseases, cardiovascular diseases, mental diseases, and immune system diseases. The company was founded on March 20, 2003 and is headquartered in Shanghai, China. | Health Technology |
| Fosun Pharma Group Co. Ltd. | |
Artisan Acquisition Corp.
 Artisan Acquisition Corp. Financial ConglomeratesFinance Artisan Acquisition Corp. operates as a blank check company. It is a special purpose acquisition company which is incorporated for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded by Chi Kong Cheng on February 2, 2021 and is headquartered in George Town, Cayman Islands. | Finance |
| Roche Diagnóstica Brasil Ltda |
